AKT1 and hepatocellular carcinoma: Activation of the Akt signaling prevents post-transcriptional degradation of FASN, SREBP1 and SREBP2 and therefore enhances de novo FA synthesis, which facilitates HCC development (Calvisi et al., 2011).